Tag Archives: Colorectal

Start screenings for colorectal cancer at age 45, panel advises

A panel of national experts on Tuesday advised earlier screenings for colorectal cancer, (colon cancer) starting at age 45 instead of 50. The U.S. Preventive Services Task Force says people aged 45 to 75 should undergo screenings as a preventative measure, with those aged 50 to 75 strongly recommended to get screened. For adults over 75, the… Read More »

FDA Approves Braftovi (encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy

Print this page April 8, 2020 – Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAFV600E mutation, as detected by an FDA-approved test, after prior… Read More »